Enriched housing down-regulates the Toll-like receptor 2 response in the mouse brain after experimental stroke

Neurobiology of Disease

Volumn 66, Issue , 2014, Pages 66-73

  Quattromani, Miriana Jlenia ^a   Cordeau, Pierre ^b   Ruscher, Karsten ^a   Kriz, Jasna ^b   Wieloch, Tadeusz ^a  

^a LUND UNIVERSITY   (Sweden)

^b CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

Bioluminescence Biophotonic imaging; Microglia; Neuroinflammation; Photothrombosis; Stroke recovery; Transgenic mice

Indexed keywords

TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CELL ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; EXPERIMENTAL STROKE; HOUSING; IMMUNOREACTIVITY; IN VIVO STUDY; INFLAMMATION; MALE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHOTOTHROMBOTIC STROKE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SENSORIMOTOR FUNCTION; SENSORY STIMULATION; TRANSCRIPTION REGULATION; UPREGULATION;

BIOLUMINESCENCE/BIOPHOTONIC IMAGING; MICROGLIA; NEUROINFLAMMATION; PHOTOTHROMBOSIS; STROKE RECOVERY; TRANSGENIC MICE;

ANIMALS; BETA-N-ACETYLHEXOSAMINIDASES; BRAIN; CELL COUNT; DOWN-REGULATION; ENCEPHALITIS; ENVIRONMENT; FLUORESCENT ANTIBODY TECHNIQUE; GREEN FLUORESCENT PROTEINS; HOUSING, ANIMAL; IMMUNOHISTOCHEMISTRY; LECTINS; LUMINESCENT MEASUREMENTS; MALE; MICE; MICE, TRANSGENIC; MICROGLIA; RECOVERY OF FUNCTION; STROKE; TOLL-LIKE RECEPTOR 2;

EID: 84897887809     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.02.010     Document Type: Article

References (50)

1. Akira S., Takeda K. Toll-like receptor signaling. Nat. Rev. Immunol. 2004, 4:499-511.
2. Anders E.P., Monika G., Mark R.W., Mogens H.C. Induction of regulatory dendritic cells by dexamethasone and 1α, 25-dihydroxyvitamin D3. Immunol. Lett. 2004, 91:63-69.
3. Arumugam T.V., Okun E., Tang S.C., Thundyil J., Taylor S.M., Woodruff T.M. Toll-like receptors in ischemia-reperfusion injury. Shock 2009, 32:4-16.
4. Asea A. Heat shock proteins and Toll-like receptors. Handb. Exp. Pharmacol. 2008, 111-127.
5. Babcock A.A., Wirenfeldt M., Holm T., Nielsen H.H., Dissing-Olesen L., Toft-Hansen H., et al. Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J. Neurosci. 2006, 26:12826-12837.
6. Bohacek I., Cordeau P., Lalancette-Hébert M., Gorup D., Weng Y.C., Gajovic S., et al. Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury. J. Neuroinflammation 2012, 9:191.
7. De Ryck M., Van Reempts J., Borgers M., Wauquier A., Janssen P. Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke 1989, 20:1383-1390.
8. Draganski B., May A. Training-induced structural changes in the adult human brain. Behav. Brain Res. 2008, 192:137-142.
9. Endres M., Engelhardt B., Koistinaho J., Lindvall O., Meairs S., Mohr J.P., et al. Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc. Dis. 2008, 25:268-278.
10. Garbuzova-Davis S., Rodrigues M.C., Hernandez-Ontiveros D.G., Tajiri N., Frisina-Deyo A., Boffeli S.M., et al. Blood-brain barrier alterations provide evidence of subacute dischisis in an ischemic stroke rat model. PLoS One 2013, e63553.
11. Hanisch U.K., Johnson T.V., Kipnis J. Toll-like receptors: roles in neuroprotection?. Trends Neurosci. 2008, 31:176-182.
12. Hunter A.J., Hatcher J., Virley D., Irving E., Hadingham S.J., Parsons A.A. Functional assessments in mice and rats after focal stroke. Neuropharmacology 2000, 39:806-816.
13. Iadecola C., Anrather J. Stroke research at a crossroad: asking the brain for directions. Nat. Neurosci. 2011, 14:1363-1368.
14. Jablonka J.A., Burnat K., Witte O.W., Kossut M. Remapping of the somatosensory cortex after a photothrombotic stroke: dynamics of the compensatory reorganization. Neuroscience 2010, 165:90-100.
15. Janssen H., Ada L., Karayanidis F., Drysdale K., McElduff P., Pollack M., et al. Translating the use of an enriched environment post stroke from bench to bedside: study design and protocol used to test the feasibility of environmental enrichment on stroke patients in rehabilitation. Int J stroke 2012, 7:521-526.
16. Johansson B.B. Current trends in stroke rehabilitation A review with focus on brain plasticity. Acta Neurol. Scand. 2011, 123:147-159.
17. Kariko K., Weissman D., Welsh F.A. Inhibition of Toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance. J. Cereb. Blood Flow Metab. 2004, 24:1288-1304.
18. Kempermann G., Neumann H. Microglia: the enemy within?. Science 2003, 302:1689-1690.
19. Kriz J., Lalancette-Hébert M. Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol. 2009, 117:497-509.
20. Lalancette-Hébert M., Phaneuf D., Soucy G., Weng Y.C., Kriz J. Live imaging of Toll-like receptor 2 response in cerebral ischaemia reveals a role of olfactory bulb microglia as modulators of inflammation. Brain 2009, 132:940-954.
21. Lehnardt S., Lehrmann S., Kaul D., Tschimmel K., Hoffmann O., Cho S., et al. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J. Neuroimaging 2007, 190:28-33.
22. Li M., Carpio D.F., Zheng Y., Bruzzo P., Singh V., Ouaaz F., et al. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 2001, 166:7128-7135.
23. Marashi V., Barnekow A., Ossendorf E., Sachser N. Effects of different forms of environmental enrichment on behavioral, endocrinological and immunological parameters in male mice. Horm. Behav. 2003, 43:281-292.
24. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
25. Moncek F., Duncko R., Johansson B.B., Jezova D. Effect of environmental enrichment on stress related systems in rats. J. Neuroendocrinol. 2004, 16:423-431.
26. Morioka T., Kalehua A.N., Streit W.J. Characterization of microglial reaction after middle cerebral artery occlusion in rat brain. J. Comp. Neurol. 1993, 327:123-132.
27. Nguyen M.D., Julien J.P., Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration?. Nat. Rev. Neurosci. 2002, 3:216-227.
28. Nithianantharajah J., Hannan A.J. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat. Rev. Neurosci. 2006, 7:697-709.
29. Nygren J., Wieloch T. Enriched environment enhances recovery of motor function after focal ischemia in mice and downregulates the transcription factor NGFI-A. J. Cereb. Blood Flow Metab. 2005, 25:1625-1633.
30. Ohlsson A.L., Johansson B.B. Environment influences functional outcome of cerebral infarction in rats. Stroke 1995, 26:644-649.
31. Paxinos G., Franklin K.B.J. The Mouse Brain 2001, Academic Press. Second edition.
32. Pekna M., Pekny M., Nilsson M. Modulation of neural plasticity as a basis for stroke rehabilitation. Stroke 2012, 43:2819-2828.
33. Perego C., Fumagalli S., De Simoni M.G. Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. J. Neuroinflammation 2011, 8:174.
34. Rogatsky I., Ivashkiv L.B. Glucocorticoid modulation of cytokine signaling. Tissue Antigens 2006, 68:1-12.
35. Ruscher K., Johannesson E., Brugiere E., Erickson A., Rickhag M., Wieloch T. Enriched environment reduces apolipoprotein E (ApoE) in reactive astrocytes and attenuates inflammation of the peri-infarct tissue after experimental stroke. J. Cereb. Blood Flow Metab. 2009, 29:1796-1805.
36. Ruscher K., Kuric E., Wieloch T. Levodopa treatment improves functional recovery after experimental stroke. Stroke 2012, 43:507-513.
37. Ruscher K., Kuric E., Wieloch T. Levodopa treatment attenuates inflammation and improves functional recovery after experimental stroke. Stroke 2012, 43:e132-e132.
38. Ruscher K., Kuric E., Liu Y., Walter H.L., Issazadeh-Navikas S., Englund E., et al. Inhibition of CXCL12 signaling attenuates the post ischemic immune response and improves functional recovery after stroke. J. Cereb. Blood Flow Metab. 2013, 33:1225-1234.
39. Schroeter M., Jander S., Witte O.W., Stoll G. Heterogeneity of the microglial response in photochemically induced focal ischemia of the rat cerebral cortex. Neuroscience 1999, 89:1367-1377.
40. Schroeter M., Jander S., Stoll G. Non-invasive induction of focal cerebral ischemia in mice by photothrombosis of cortical microvessels: characterization of inflammatory responses. J. Neurosci. Methods 2002, 1:43-49.
41. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., Sharp F.R. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 1990, 10:290-293.
42. Tang S.C., Arumugam T.V., Xu X., Cheng A., Mughal M.R., Jo D.G., et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13798-13803.
43. Truckenmiller M.E., Princiotta M.F., Norbury C.C., Bonneau R.H. Corticosterone impairs MHC class I antigen presentation by dendritic cells via reduction of peptide generation. J. Neuroimmunol. 2005, 160:48-60.
44. Van Praag H., Kempermann G., Gage F.H. Neural consequences of environmental enrichment. Nat. Rev. Neurosci. 2000, 1:191-198.
45. Vieira P.L., Kalinski P., Wierenga E.A., Kapsenberg M.L., de Jong E.C. Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J. Immunol. 1998, 161:5245-5251.
46. Watson B.D., Dietrich W.D., Busto R., Wachtel M.S., Ginsberg M.D. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann. Neurol. 1985, 17:497-504.
47. Webster J.I., Tonelli L., Sternberg E.M. Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 2002, 20:125-163.
48. Wieloch T., Nikolich K. Mechanisms of neural plasticity following brain injury. Curr. Opin. Neurobiol. 2006, 16:258-264.
49. Ziegler G., Harhausen D., Schepers C., Hoffmann O., Röhr C., Prinz V., et al. TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem. Biophys. Res. Commun. 2007, 359:574-579.
50. Ziegler G., Freyer D., Harhausen D., Khojasteh U., Nietfeld W., Trendelenburg G. Blocking TLR2 in vivo protects against accumulation of inflammatory cells and neuronal injury in experimental stroke. J. Cereb. Blood Flow Metab. 2010, 31:757-766.